Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
InnoPharma, Inc. logo — company profile

InnoPharma, Inc.

Founded 2005 United States Piscataway, United States 10 employees Debt Financing Total: $43.00M Biotechnology, Pharmaceutical

General Information

Company Name InnoPharma, Inc.
Founded Year 2005
Location United States Piscataway, United States
Employees 10
Industries Biotechnology, Pharmaceutical
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with InnoPharma, Inc.. To contact InnoPharma, Inc., visit innopharmainc.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About InnoPharma, Inc.

InnoPharma, Inc., **founded in 2005** and headquartered in the **United States**, was acquired by Pfizer, Inc. on September 25, 2014. The company specializes in developing **niche generic and specialty pharmaceutical/bio-pharmaceutical products** in sterile dosage forms and out-licenses them to pharmaceutical marketing companies for commercialization. The company’s “Niche Generics” program focuses on developing generic drug products that are challenging to develop for technical reasons, have limited active pharmaceutical ingredient (API) sources, cater to niche areas of use, involve complicated manufacturing and bio-equivalency or clinical studies, and provide value in terms of cost effectiveness to patients and prescribers. Notably, their last investment amounted to **$20.00M in Debt Financing** from **Athyrium Capital Management** on **November 13, 2013**. InnoPharma, Inc.'s acquisition by Pfizer underscores its potential and the attractiveness of its business model in the biotechnology and pharmaceutical industries. For more information, visit InnoPharma, Inc. at [innopharmainc.com.](http://innopharmainc.com)

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $20.00M 1
Athyrium Capital Management
Athyrium Capital Management
13 Nov 2013
Debt Financing $8.00M 3
Armentum Partners NXT Capital
Armentum Partners, NXT Capital +1
07 Jun 2012
Series A $15.00M 1
Thomas, McNerney & Partners
Thomas, McNerney & Partners
02 Dec 2011

FAQ About InnoPharma, Inc.

Innopharma, Inc. was acquired by Pfizer, Inc on September 25, 2014. https://www.pfizer.com/news/press-release/press-release-detail/pfizer_completes_acquisition_of_innopharma ----------------------------------------------------------------------------------------------------------------------------...
InnoPharma, Inc. was founded in 2005.
InnoPharma, Inc. is headquartered in Piscataway, United States.
InnoPharma, Inc. operates in Biotechnology and Pharmaceutical.
InnoPharma, Inc. has approximately 10 employees.
InnoPharma, Inc. has completed 3 funding rounds, raising a total of $43.00M. The latest funding stage is Debt Financing.

We're actively collecting intelligence on InnoPharma, Inc..

Source: BounceWatch company record for InnoPharma, Inc., https://bouncewatch.com/company/innopharma, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes